Grace Breeding Past Earnings Performance
Past criteria checks 0/6
Grace Breeding's earnings have been declining at an average annual rate of -19%, while the Biotechs industry saw earnings growing at 11.1% annually. Revenues have been growing at an average rate of 31.7% per year.
Key information
-19.0%
Earnings growth rate
4.3%
EPS growth rate
| Biotechs Industry Growth | -24.5% |
| Revenue growth rate | 31.7% |
| Return on equity | -652.8% |
| Net Margin | -1,117.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Grace Breeding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -5 | 4 | 2 |
| 31 Mar 24 | 0 | -7 | 5 | 2 |
| 31 Dec 23 | 0 | -9 | 6 | 3 |
| 30 Jun 23 | 0 | -10 | 6 | 4 |
| 31 Mar 23 | 0 | -11 | 6 | 5 |
| 31 Dec 22 | 0 | -11 | 6 | 5 |
| 30 Sep 22 | 0 | -10 | 5 | 4 |
| 30 Jun 22 | 0 | -9 | 4 | 3 |
| 31 Mar 22 | 0 | -7 | 3 | 2 |
| 31 Dec 21 | 0 | -5 | 2 | 1 |
| 30 Sep 21 | 0 | -4 | 1 | 1 |
| 30 Jun 21 | 0 | -3 | 1 | 2 |
| 31 Mar 21 | 0 | -4 | 1 | 2 |
| 31 Dec 20 | 0 | -4 | 1 | 2 |
| 31 Dec 19 | 0 | -4 | 1 | 2 |
Quality Earnings: GRAC is currently unprofitable.
Growing Profit Margin: GRAC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GRAC is unprofitable, and losses have increased over the past 5 years at a rate of 19% per year.
Accelerating Growth: Unable to compare GRAC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GRAC is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (7.1%).
Return on Equity
High ROE: GRAC has a negative Return on Equity (-652.78%), as it is currently unprofitable.